Prenosis

Breaking News! Prenosis — an artificial intelligence company enabling precision medicine in acute care — is proud to announce that the FDA has granted marketing authorization (De Novo pathway) for the Sepsis ImmunoScore™, our AI diagnostic and predictive tool for early detection of sepsis. This signifies the first-ever FDA marketing authorization of an AI diagnostic tool for sepsis. Sepsis, a complex and deadly condition, claims more lives than all cancers combined. https://lnkd.in/g-crKfn6 Join us in celebrating this historic “first" for healthcare innovation! #Sepsis #AI #FDAApproval #Prenosis 

Artigo publicado no NEJM AI descreve o primeiro software baseado em IA aprovado pelo FDA para prever casos de #sepse. Chamado de Sepsis ImmunoScore, o algoritmo identifica pacientes em risco de sepse e prevê desfechos adversos que podem ocorrer nas próximas 24h. O Sepsis ImmunoScore categoriza os pacientes em quatro níveis de risco: baixo, médio, alto e muito alto. Esses níveis correlacionaram-se com desfechos como mortalidade, admissão em UTI, uso de ventilação mecânica e de vasopressores. O algoritmo também ajudou a discriminar entre pacientes com sepse no momento da avaliação inicial e aqueles que desenvolveriam sepse dentro de 24 horas, destacando seu valor tanto como ferramenta para diagnóstico quanto prognóstico. Com a aprovação será possível evoluir nas análises de custo-efetividade e impacto na qualidade de vida dos pacientes. Vale a leitura!

A big thank you to 360Dx for highlighting our groundbreaking work! Its article dives into the details of Prenosis' latest achievement: the publication of a pivotal study in NEJM AI--showcasing the validation and FDA authorization of our AI-based Sepsis ImmunoScore™--as well as our future plans. This recognition underscores the impact of our work in transforming precision medicine for acute care. Sepsis remains one of the leading causes of death worldwide, and tools like the Sepsis ImmunoScore™ are paving the way for earlier detection and improved outcomes. We’re grateful to 360Dx for bringing attention to this important milestone and recognizing the potential of AI-driven diagnostics to revolutionize healthcare. Read the full article here (Subscription Required): https://lnkd.in/gfYGuSCq #PrecisionDiagnostics #AIinHealthcare #SepsisAwareness #Prenosis

Proud to see the December issue of NEJM AI (Volume 1, No. 12) now available, featuring our paper: ⚕️ FDA-Authorized AI/ML Tool for Sepsis Prediction: Development and Validation Grateful for the chance to contribute to the critical dialogue on advancing sepsis diagnostics and patient care. Read more here: https://prenosis.com/nejm/ #AI #Sepsis #NEJMAI

Curious about how #AI is transforming sepsis diagnosis and driving SEP-1 bundle compliance? Join Akhil Bhargava at Booth #416 during the #IHIForum 2024 to learn how cutting-edge tools like the Sepsis ImmunoScore™ can enhance provider support and improve outcomes. Don’t miss this opportunity to explore the future of AI in healthcare! #SepsisCare #IHIForum2024 #SEP1Compliance #HealthcareInnovation #AIInHealthcare

Looking to improve SEP-1 bundle compliance and elevate your sepsis care? The Sepsis ImmunoScore™, the first FDA-authorized AI diagnostic for sepsis, can make a real difference. Stop by Booth #416 at the #IHIForum 2024 and chat with Prenosis' Jim Sianis, B.S., PharmD, MBA to discover how this groundbreaking tool can transform your sepsis diagnostics. #SepsisCare #IHIForum2024 #SEP1Compliance #HealthcareInnovation #PrecisionDiagnostics

Thrilled to announce that our groundbreaking study has been published in the NEJM AI: https://lnkd.in/gZvaYFWN The paper highlights the predictive power of Sepsis ImmunoScore™. Prenosis' Sepsis ImmunoScore™—the first FDA-authorized AI diagnostic tool for sepsis—not only demonstrates high accuracy in diagnosing sepsis but also shows significant predictive power for key adverse patient outcomes. This marks a monumental step forward in sepsis care, highlighting the transformative potential of #AI in healthcare. Sepsis claims the lives of at least 350,000 people annually in the U.S.—more than all cancers combined—and costs the healthcare system billions of dollars each year. With the Sepsis ImmunoScore™, we're ushering in a new era of predictive tools powered by AI, moving from reactive treatment to proactive management. A heartfelt thank you to our incredible team at Prenosis and all our collaborators who made this possible. Together, we're advancing the era of prenostics, where AI doesn't just diagnose—it anticipates. Learn more about our study and join us in transforming patient care. #AI #SepsisCare #HealthcareInnovation #Prenosis #SepsisImmunoScore #NEJMAI

Heading to the #IHIForum in Orlando, December 8-11? Prenosis will be there, showcasing how our FDA-authorized Sepsis ImmunoScore™ helps providers improve SEP-1 bundle compliance. Stop by Booth #416 to discover how our innovative approach to precision diagnostics is transforming sepsis care. We’re excited to connect and share insights with the healthcare quality community. #PrecisionDiagnostics #SepsisCare #HealthcareInnovation

We are thrilled to announce that our Sepsis ImmunoScore™ has been recognized as one of TIME's Best Inventions of 2024! We are honored to be featured among the world’s most transformative inventions. With thousands of submissions from across the globe, it’s an incredible achievement to stand out in such prestigious company. The Sepsis ImmunoScore™ is the first FDA-authorized AI diagnostic for sepsis, a groundbreaking achievement that marks a new era in precision diagnostics. This recognition is a testament to the incredible dedication of our Prenosis team, as well as the collaboration with our healthcare partners who continue to trust and believe in the power of innovation to save lives. Thank you to everyone who has been part of this journey. You can read the TIME article here: https://lnkd.in/gzj9erxz #TIMEBestInventions #SepsisImmunoScore #PrecisionDiagnostics #AIInHealthcare #SepsisAwareness #InnovationInHealthcare #Prenosis #HealthcareInnovation

Sepsis continues to be one of the leading causes of preventable deaths in healthcare, with up to 1.7 million cases each year in the U.S. alone, resulting in nearly 270,000 fatalities. The recent Agency for Healthcare Research and Quality (AHRQ) report on sepsis care shines a spotlight on these figures, encouraging us to come together to identify and treat sepsis earlier and more effectively. The report emphasizes the importance of early recognition and swift intervention, which can significantly improve patient outcomes and reduce mortality. https://lnkd.in/eXCDcqdG